-
ImmunoTargets and Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Dr Shurin
Editor-in-Chief: Michael R Shurin
Dr Shurin is an Associate Professor of Pathology and Immunology at the University of Pittsburgh Medical Center and an Associate Director of the Division of Clinical Immunopathology. After graduation from Medical School in Moscow and additional clinical training, Dr Shurin proceeded his research career and obtained a PhD degree in Immunopharmacology from the State Research institute for Pharmacology in Moscow, Russia. From 1991, Dr Shurin was a faculty at the University of Pittsburgh. He leads a unique research program focusing on cellular and molecular interactions in the tumor microenvironment and supported by NIH.
He is well known for his studies on dendritic cells in cancer. Dr Shurin has published more than 150 papers, reviews and book chapters, edited two books, organized several international conferences on immune-mediated diseases, immunodiagnostics and cancer immunotherapy. He served on NIH, DoD and ACS study session, several editorial boards and advisory committees.
-
Call For Submissions
Submit Original Research Article, Review, Case Report, or Rapid Communication in ImmunoTargets and Therapy
